Smell Preservation after SARS-CoV-2 Infection and Endoscopic Skull Base Surgery: A Favorable Result

Background: Previous studies have clearly documented the association between SARS-CoV-2 infection and olfactory dysfunction (OD). However, little is known about the effect of SARS-CoV-2 infection on postoperative olfactory function after endoscopy skull base surgery (ESBS). This study aims to evaluate the impact of SARS-CoV-2 infection on the postoperative olfactory function in patients who underwent ESBS for a pituitary tumor.

Methods: A retrospective case–control study of patients who underwent ESBS from 2020 to 2022. A total of 59 patients met inclusion criteria. All patients completed a preoperative and 12-week postoperative assessment of olfactory function using the University of Pennsylvania Smell Identification Test (UPSIT). Patients were stratified into two groups according to their SARS-CoV-2 status: patients with history of previous SARS-CoV-2 infection (n = 17), and those with no documented history of SARS-CoV-2 infection (n = 42). A nonparametric analysis was completed.

Results: No significant change in mean UPSIT score was noted between the preoperative and 12-week postoperative UPSIT scores among the overall cohort (p = 0.719). No difference between preoperative and postoperative UPSIT scores was observed in those with a positive history of SARS-CoV-2 infection (p = 0.07, p = 0.60). 17.6% of patients with a history of SARS-CoV-2 infection reported loss or reduction in smell at the time of infection and the average rate of infection was 3.44 months (IQ: 1–4.75 months) before ESBS.

Conclusion: History of SARS-CoV-2 infection is not associated with olfactory dysfunction after ESBS. Patients with a history of previous SARS-CoV-2 infection did not have worse pre and postoperative scores compared to those that were never infected.

 

Scroll to top

No conflict of interest has been declared by the author(s).

Publication History

Article published online:
05 February 2024